Esbamax NAC Effervescent Tablets
Natural health product licensed in Canada
- Licence holder
- 7099681 Canada Inc. DBA ESBAMAX GLOBAL ALLIANCE
- NPN or DIN-HM
- 80116575
- Status
- Active licence
- Licence date
- 21 February 2022
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 600 mg | Not calculated |
Non-medicinal ingredients
Povidone, Saveur de citron, Acide citrique, Aspartame, Benzoate de sodium, Maltodextrine, Saveur, Sucralose, Bicarbonate de sodium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. A factor in the maintenance of good health. Helps (to) maintain/support immune function. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in wound healing and connective tissue formation. Helps to maintain the body's ability to metabolize nutrients. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80116575
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.